Andere Sprachen SIGN THERPAR

Aktien

A401WX

US82674U2050

SIGY

Markt geschlossen - OTC Markets Andere Börsenplätze 18:27:32 15.05.2024			% 5 Tage	% 1. Jan.
5.25 ^USD	+5.00%		-.--%	+10.99%

14.05.	Sigyn Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
20.02.	Sigyn Therapeutics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Sigyn Therapeutics Reports First Quarter 2024 Financial Results	15.05.
Sigyn Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"	07.05.
Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference	05.03.
Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K	21.02.
Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20.02.
Sigyn Therapeutics Announces Reverse Stock Split	30.01.
Sigyn Therapeutics Releases Letter to Shareholders	04.01.
Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer	12.12.
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer	12.12.
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results	14.11.
Sigyn Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity	04.10.23
Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference	06.09.23
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results	14.08.23
Sigyn Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Sigyn Therapeutics to Present at Tomorrow’s Emerging Growth Conference	08.08.23
Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd	31.07.23
Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application	17.05.23
Sigyn Therapeutics, Inc. Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep Trademark Application	17.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SIGN THERPAR

Aktien

A401WX

US82674U2050

SIGY

Andere Sprachen

Filter